Italian COVID-19 vaccine shows strong immune response in mid-stage trial

Italy's hopes of producing its own COVID-19 vaccine were given a boost on Monday when local biotech firm ReiThera said its vaccine candidate showed a strong immune response and no major side effects in intermediate Phase II clinical trials.